SGX 523Alternative Names: SGX-70329; SGX029; SGX523
Latest Information Update: 20 May 2008
At a glance
- Originator SGX Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action Proto oncogene protein c met inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Solid tumours